Detalhe da pesquisa
1.
Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an open-label, multicentre, safety study.
Lancet Oncol
; 15(4): 436-44, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24582505
2.
Vemurafenib in patients with BRAF(V600) mutation-positive melanoma with symptomatic brain metastases: final results of an open-label pilot study.
Eur J Cancer
; 50(3): 611-21, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24295639
3.
Vemurafenib in Patients With Relapsed Refractory Multiple Myeloma Harboring BRAF V600 Mutations: A Cohort of the Histology-Independent VE-BASKET Study.
JCO Precis Oncol
; 22018.
Artigo
em Inglês
| MEDLINE | ID: mdl-32913989